{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:26Z","timestamp":1786982126362,"version":"build-2736575974"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11897-025-00718-9","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:53:59Z","timestamp":1760342039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex Differences in Chagas Cardiomyopathy: a Comprehensive Review"],"prefix":"10.1007","volume":"22","author":[{"given":"Antonio de Padua","family":"Mansur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edecio","family":"Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo Bulgarelli","family":"Bestetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Brochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chevillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos","family":"Pereira-Barretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edimar Alcides","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"issue":"12","key":"718_CR1","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1161\/CIR.0000000000000599","volume":"138","author":"MCP Nunes","year":"2018","unstructured":"Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverr\u00eda LE, et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018;138(12):e169\u2013209. https:\/\/doi.org\/10.1161\/CIR.0000000000000599.","journal-title":"Circulation"},{"key":"718_CR2","unstructured":"World Health Organization. Chagas disease (American trypanosomiasis). Published June 14. 2023. Accessed 22 May 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chagas-disease-(american-trypanosomiasis)."},{"key":"718_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2017.05.001","volume":"43","author":"S Antinori","year":"2017","unstructured":"Antinori S, Galimberti L, Bianco R, Grande R, Galli M, Corbellino M. Chagas disease in Europe: a review for the internist in the globalized world. Eur J Intern Med. 2017;43:6\u201315. https:\/\/doi.org\/10.1016\/j.ejim.2017.05.001.","journal-title":"Eur J Intern Med"},{"key":"718_CR4","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3201\/eid2807.212221","volume":"28","author":"A Irish","year":"2022","unstructured":"Irish A, Whitman JD, Clark EH, Marcus R, Bern C. Updated estimates and mapping for prevalence of Chagas disease among adults united states. Emerg Infect Dis. 2022;28:1313. https:\/\/doi.org\/10.3201\/eid2807.212221.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"718_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00023-19","volume":"33","author":"C Bern","year":"2019","unstructured":"Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019;33(1):e00023\u201319. https:\/\/doi.org\/10.1128\/CMR.00023-19.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"718_CR6","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/heart.89.10.1186","volume":"89","author":"AL Basquiera","year":"2003","unstructured":"Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzm\u00e1n S, Moreno Barral J, et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart. 2003;89(10):1186\u201390. https:\/\/doi.org\/10.1136\/heart.89.10.1186.","journal-title":"Heart"},{"key":"718_CR7","doi-asserted-by":"publisher","unstructured":"Sabino EC, Ribeiro AL, Salemi VM, Di Lorenzo Oliveira C, Antunes AP, Menezes MM, et al. Ten-year incidence of Chagas cardiomyopathy among asymptomatic trypanosoma cruzi-seropositive former blood donors. Circulation. 2013;127(10):1105\u201315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.123612.","DOI":"10.1161\/CIRCULATIONAHA.112.123612"},{"key":"718_CR8","first-page":"225","volume":"4","author":"AC Pereira-Barretto","year":"1993","unstructured":"Pereira-Barretto AC, Arteaga E, Mady C, Ianni BM, Bellotti G, Pileggi F. Male sex. A prognostic factor in chagas\u2019 disease. Arq Bras Cardiol. 1993;4:225\u20137.","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"718_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-016-0307-5","volume":"18","author":"AN Assun\u00e7\u00e3o Jr","year":"2016","unstructured":"Assun\u00e7\u00e3o AN Jr, Jerosch-Herold M, Melo RL, Mauricio AV, Rocha L, Torre\u00e3o JA, et al. Chagas\u2019 heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2016;18(1):88. https:\/\/doi.org\/10.1186\/s12968-016-0307-5.","journal-title":"J Cardiovasc Magn Reson"},{"key":"718_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02408-5","author":"AMK Minhas","year":"2024","unstructured":"Minhas AMK, Marcus R, Virani SS, Shapiro MD, Mentz RJ, Echeverria LE, et al. Worldwide prevalence of Chagas cardiomyopathy-an analysis from the global burden of disease dataset. Infection. 2024. https:\/\/doi.org\/10.1007\/s15010-024-02408-5.","journal-title":"Infection"},{"issue":"1","key":"718_CR11","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1150","volume":"17","author":"SA G\u00f3mez-Ochoa","year":"2022","unstructured":"G\u00f3mez-Ochoa SA, Rojas LZ, Echeverr\u00eda LE, Muka T, Franco OH. Global, regional, and national trends of Chagas disease from 1990 to 2019: comprehensive analysis of the global burden of disease study. Glob Heart. 2022;17(1):59. https:\/\/doi.org\/10.5334\/gh.1150.","journal-title":"Glob Heart"},{"key":"718_CR12","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. DATASUS. Bras\u00edlia. 2025. Available online: http:\/\/tabnet.datasus.gov.br\/cgi\/tabcgi.exe?sim\/cnv\/obt10uf.def. Accessed in 14 Aug 2025."},{"key":"718_CR13","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. In: Boletim Epidemiol\u00f3gico: An\u00e1lise descritiva: um ano de implementa\u00e7\u00e3o da notifica\u00e7\u00e3o de doen\u00e7a de Chagas cr\u00f4nica no Brasil. 2024. https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/edicoes\/2024\/boletim-epidemiologico-volume-55-no-08.pdf. Accessed in 24 Jul 2025."},{"key":"718_CR14","doi-asserted-by":"publisher","unstructured":"Hidron AI, Gilman RH, Justiniano J, Blackstock AJ, Lafuente C, Selum W, et al. Chagas cardiomyopathy in the context of the chronic disease transition. PLoS Negl Trop Dis. 2010;4(5):e688. https:\/\/doi.org\/10.1371\/journal.pntd.0000688.","DOI":"10.1371\/journal.pntd.0000688"},{"key":"718_CR15","doi-asserted-by":"publisher","DOI":"10.1590\/0074-02760210172","volume":"117","author":"RM Torres","year":"2022","unstructured":"Torres RM, Correia D, Nunes MDCP, Dutra WO, Talvani A, Sousa AS, et al. Prognosis of chronic Chagas heart disease and other pending clinical challenges. Mem Inst Oswaldo Cruz. 2022;117:e210172. https:\/\/doi.org\/10.1590\/0074-02760210172.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"718_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ajpath.2011.09.006","volume":"180","author":"M Torzewski","year":"2012","unstructured":"Torzewski M, Wenzel P, Kleinert H, Becker C, El-Masri J, Wiese E, et al. Chronic inflammatory cardiomyopathy of interferon \u03b3-overexpressing transgenic mice is mediated by tumor necrosis factor-\u03b1. Am J Pathol. 2012;180(1):73\u201381. https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.006.","journal-title":"Am J Pathol"},{"issue":"10","key":"718_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.rec.2024.02.014","volume":"77","author":"SA G\u00f3mez-Ochoa","year":"2024","unstructured":"G\u00f3mez-Ochoa SA, Serrano-Garc\u00eda AY, Hurtado-Ortiz A, Aceros A, Rojas LZ, Echeverr\u00eda LE. A systematic review and meta-analysis of mortality in chronic Chagas cardiomyopathy versus other cardiomyopathies: higher risk or fiction? Rev Esp Cardiol. 2024;77(10):843\u201350. https:\/\/doi.org\/10.1016\/j.rec.2024.02.014.","journal-title":"Rev Esp Cardiol"},{"key":"718_CR18","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0225-2020","volume":"53","author":"KCF Lidani","year":"2020","unstructured":"Lidani KCF, Sandri TL, Castillo-Neyra R, Andrade FA, Guimar\u00e3es CM, Marques EN, et al. Clinical and epidemiological aspects of chronic Chagas disease from Southern Brazil. Rev Soc Bras Med Trop. 2020;53:e20200225. https:\/\/doi.org\/10.1590\/0037-8682-0225-2020.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"7","key":"718_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s1286-4579(00)00501-3","volume":"2","author":"KC Fa\u00e9","year":"2000","unstructured":"Fa\u00e9 KC, Drigo SA, Cunha-Neto E, Ianni B, Mady C, Kalil J, Goldberg AC. HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect. 2000;2(7):745\u201351. https:\/\/doi.org\/10.1016\/s1286-4579(00)00501-3.","journal-title":"Microbes Infect"},{"issue":"4","key":"718_CR20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4269\/ajtmh.22-0630","volume":"108","author":"MK Cutshaw","year":"2023","unstructured":"Cutshaw MK, Sciaudone M, Bowman NM. Risk factors for progression to chronic Chagas cardiomyopathy: a systematic review and meta-analysis. Am J Trop Med Hyg. 2023;108(4):791\u2013800. https:\/\/doi.org\/10.4269\/ajtmh.22-0630.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"718_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/eci.12.10","volume":"8","author":"D Fairweather","year":"2012","unstructured":"Fairweather D, Petri MA, Coronado MJ, Cooper LT. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol. 2012;8(3):269\u201384. https:\/\/doi.org\/10.1586\/eci.12.10.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"718_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medsci13030083","volume":"13","author":"VJ Varughese","year":"2025","unstructured":"Varughese VJ, Mohamed A, Nagesh VK, Atoot A. National trends in admissions, treatments, and outcomes for dilated cardiomyopathy (2016\u20132021). Med Sci. 2025;13(3):83. https:\/\/doi.org\/10.3390\/medsci13030083.","journal-title":"Med Sci"},{"issue":"1","key":"718_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/jaut.2001.0523","volume":"17","author":"LC Abel","year":"2001","unstructured":"Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, et al. Chronic chagas\u2019 disease cardiomyopathy patients display an increased IFN-gamma response to trypanosoma Cruzi infection. J Autoimmun. 2001;17(1):99\u2013107. https:\/\/doi.org\/10.1006\/jaut.2001.0523.","journal-title":"J Autoimmun"},{"issue":"3","key":"718_CR24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/IAI.71.3.1185-1193.2003","volume":"71","author":"JA Gomes","year":"2003","unstructured":"Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas\u2019 disease is due to a Th1-specific immune response. Infect Immun. 2003;71(3):1185\u201393. https:\/\/doi.org\/10.1128\/IAI.71.3.1185-1193.2003.","journal-title":"Infect Immun"},{"issue":"3","key":"718_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087082","volume":"9","author":"GR Sousa","year":"2014","unstructured":"Sousa GR, Gomes JA, Fares RC, Dam\u00e1sio MP, Chaves AT, Ferreira KS, et al. Plasma cytokine expression is associated with cardiac morbidity in Chagas disease. PLoS ONE. 2014;9(3):e87082. https:\/\/doi.org\/10.1371\/journal.pone.0087082.","journal-title":"PLoS ONE"},{"key":"718_CR26","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.2741\/2273","volume":"12","author":"FF Araujo","year":"2007","unstructured":"Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R. Potential role of CD4\u2009+\u2009CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci. 2007;12:2797\u2013806. https:\/\/doi.org\/10.2741\/2273.","journal-title":"Front Biosci"},{"issue":"4","key":"718_CR27","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.micinf.2005.01.001","volume":"7","author":"SG Fonseca","year":"2005","unstructured":"Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, Mady C, et al. Identification of multiple HLA-A*0201-restricted Cruzipain and FL-160 CD8\u2009+\u2009epitopes recognized by T cells from chronically trypanosoma cruzi-infected patients. Microbes Infect. 2005;7(4):688\u201397. https:\/\/doi.org\/10.1016\/j.micinf.2005.01.001.","journal-title":"Microbes Infect"},{"issue":"8","key":"718_CR28","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1172\/JCI118969","volume":"98","author":"E Cunha-Neto","year":"1996","unstructured":"Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J. Autoimmunity in chagas\u2019 disease. Identification of cardiac myosin-B13 trypanosoma Cruzi protein crossreactive T cell clones in heart lesions of a chronic chagas\u2019 cardiomyopathy patient. J Clin Invest. 1996;98(8):1709\u201312. https:\/\/doi.org\/10.1172\/JCI118969.","journal-title":"J Clin Invest"},{"issue":"2","key":"718_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/clin.1997.4335","volume":"83","author":"MM Reis","year":"1997","unstructured":"Reis MM, Higuchi ML, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, et al. An in situ quantitative immunohistochemical study of cytokines and IL-2R\u2009+\u2009in chronic human Chagasic myocarditis: correlation with the presence of myocardial trypanosoma Cruzi antigens. Clin Immunol Immunopathol. 1997;83(2):165\u201372. https:\/\/doi.org\/10.1006\/clin.1997.4335.","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"718_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0002-9440(10)62976-8","volume":"167","author":"E Cunha-Neto","year":"2005","unstructured":"Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in chagas\u2019 disease cardiomyopathy. Am J Pathol. 2005;167(2):305\u201313. https:\/\/doi.org\/10.1016\/S0002-9440(10)62976-8.","journal-title":"Am J Pathol"},{"issue":"10","key":"718_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001867","volume":"6","author":"LG Nogueira","year":"2012","unstructured":"Nogueira LG, Santos RH, Ianni BM, Fiorelli AI, Mairena EC, Benvenuti LA, et al. Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis. 2012;6(10):e1867. https:\/\/doi.org\/10.1371\/journal.pntd.0001867.","journal-title":"PLoS Negl Trop Dis"},{"key":"718_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/914326","volume":"2014","author":"LG Nogueira","year":"2014","unstructured":"Nogueira LG, Santos RH, Fiorelli AI, Mairena EC, Benvenuti LA, Bocchi EA, et al. Myocardial gene expression of T-bet, GATA-3, Ror-\u03b3t, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response. Mediators Inflamm. 2014;2014:914326. https:\/\/doi.org\/10.1155\/2014\/914326.","journal-title":"Mediators Inflamm"},{"issue":"10","key":"718_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1161\/CIRCULATIONAHA.121.055888","volume":"145","author":"G Feng","year":"2022","unstructured":"Feng G, Bajpai G, Ma P, Koenig A, Bredemeyer A, Lokshina I, et al. CCL17 aggravates myocardial injury by suppressing recruitment of regulatory T cells. Circulation. 2022;145(10):765\u201382. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055888.","journal-title":"Circulation"},{"issue":"4","key":"718_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MOG.0b013e328339d099","volume":"26","author":"W Strober","year":"2010","unstructured":"Strober W, Zhang F, Kitani A, Fuss I, Fichtner-Feigl S. Proinflammatory cytokines underlying the inflammation of Crohn\u02bcs disease. Curr Opin Gastroenterol. 2010;26(4):310\u20137. https:\/\/doi.org\/10.1097\/MOG.0b013e328339d099.","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"718_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/infdis\/jis724","volume":"207","author":"LM Magalh\u00e3es","year":"2013","unstructured":"Magalh\u00e3es LM, Villani FN, Nunes Mdo C, Gollob KJ, Rocha MO, Dutra WO. High Interleukin 17 expression is correlated with better cardiac function in human Chagas disease. J Infect Dis. 2013;207(4):661\u20135. https:\/\/doi.org\/10.1093\/infdis\/jis724.","journal-title":"J Infect Dis"},{"issue":"2","key":"718_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.it.2025.01.001","volume":"46","author":"Y Wen","year":"2025","unstructured":"Wen Y, Xia Y, Yang X, Li H, Gao Q. CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells. Trends Immunol. 2025;46(2):153\u201365. https:\/\/doi.org\/10.1016\/j.it.2025.01.001.","journal-title":"Trends Immunol"},{"issue":"2","key":"718_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.24875\/ACM.23000018","volume":"94","author":"OA Reboreda-Hernandez","year":"2024","unstructured":"Reboreda-Hernandez OA, Ortiz-Butron R, Nogueda-Torres B, Gonzalez-Rodriguez N. Influence of sexual hormones on Chagas disease. Arch Cardiol Mex. 2024;94(2):127\u201332. https:\/\/doi.org\/10.24875\/ACM.23000018.","journal-title":"Arch Cardiol Mex"},{"key":"718_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fendo.2018.00334","volume":"9","author":"AR P\u00e9rez","year":"2018","unstructured":"P\u00e9rez AR, Morrot A, Carvalho VF, de Meis J, Savino W. Role of hormonal circuitry upon T cell development in Chagas disease: possible implications on T cell dysfunctions. Front Endocrinol (Lausanne). 2018;9:334. https:\/\/doi.org\/10.3389\/fendo.2018.00334.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"718_CR39","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2024.41","volume":"27","author":"O Battistoni","year":"2025","unstructured":"Battistoni O, Huston RH, Verma C, Pacheco-Fernandez T, Abul-Khoudoud S, Campbell A, et al. Understanding sex-biases in kinetoplastid infections: leishmaniasis and trypanosomiasis. Expert Rev Mol Med. 2025;27:e7. https:\/\/doi.org\/10.1017\/erm.2024.41.","journal-title":"Expert Rev Mol Med"},{"key":"718_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yhbeh.2016.11.017","volume":"88","author":"J Roved","year":"2017","unstructured":"Roved J, Westerdahl H, Hasselquist D. Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences. Horm Behav. 2017;88:95\u2013105. https:\/\/doi.org\/10.1016\/j.yhbeh.2016.11.017.","journal-title":"Horm Behav"},{"issue":"1","key":"718_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/IAI.67.1.308-318.1999","volume":"67","author":"CR Marinho","year":"1999","unstructured":"Marinho CR, D\u2019Imp\u00e9rio Lima MR, Grisotto MG, Alvarez JM. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of chagas\u2019 disease. Infect Immun. 1999;67(1):308\u201318. https:\/\/doi.org\/10.1128\/IAI.67.1.308-318.1999.","journal-title":"Infect Immun"},{"issue":"12","key":"718_CR42","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.micinf.2003.07.001","volume":"5","author":"AM Bilate","year":"2003","unstructured":"Bilate AM, Salemi VM, Ramires FJ, de Brito T, Silva AM, Umezawa ES, et al. The Syrian hamster as a model for the dilated cardiomyopathy of chagas\u2019 disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect. 2003;5(12):1116\u201324. https:\/\/doi.org\/10.1016\/j.micinf.2003.07.001.","journal-title":"Microbes Infect"},{"key":"718_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.741347","volume":"8","author":"MT Oliveira","year":"2021","unstructured":"Oliveira MT, Schmidt A, Silva MC, Donadi EA, da Silva JS, Marin-Neto JA. Parasitic load correlates with left ventricular dysfunction in patients with chronic Chagas cardiomyopathy. Front Cardiovasc Med. 2021;8:741347. https:\/\/doi.org\/10.3389\/fcvm.2021.741347.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"718_CR44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ejhf.220","volume":"17","author":"EC Sabino","year":"2015","unstructured":"Sabino EC, Ribeiro AL, Lee TH, Oliveira CL, Carneiro-Proietti AB, Antunes AP, et al. Detection of trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity. Eur J Heart Fail. 2015;17(4):416\u201323. https:\/\/doi.org\/10.1002\/ejhf.220.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"718_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010044","volume":"25","author":"A Sunderraj","year":"2023","unstructured":"Sunderraj A, Cunha LM, Avila M, Alexandria S, Ferreira AM, de Oliveira- Silva LC, et al. Parasite DNA and markers of decreased immune activation associate prospectively with cardiac functional decline over 10 years among trypanosoma cruzi seropositive individuals in Brazil. Int J Mol Sci. 2023;25(1):44. https:\/\/doi.org\/10.3390\/ijms25010044.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"718_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perry JB, Allen ME, Sabbah HN, Stauffer BL, Shaikh SR, et al. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14(4):238\u201350. https:\/\/doi.org\/10.1038\/nrcardio.2016.203.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"718_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1590\/s0066-782x2010005000099","volume":"95","author":"AM Leme","year":"2010","unstructured":"Leme AM, Salemi VM, Parga JR, Ianni BM, Mady C, Weiss RG, Kalil-Filho R. Evaluation of the metabolism of high energy phosphates in patients with chagas\u2019 disease. Arq Bras Cardiol. 2010;95(2):264\u201370. https:\/\/doi.org\/10.1590\/s0066-782x2010005000099.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"718_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001205","volume":"5","author":"PC Teixeira","year":"2011","unstructured":"Teixeira PC, Santos RH, Fiorelli AI, Bilate AM, Benvenuti LA, Stolf NA, et al. Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy. PLoS Negl Trop Dis. 2011;5(6):e1205. https:\/\/doi.org\/10.1371\/journal.pntd.0001205.","journal-title":"PLoS Negl Trop Dis"},{"key":"718_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.755782","volume":"12","author":"PC Teixeira","year":"2021","unstructured":"Teixeira PC, Ducret A, Langen H, Nogoceke E, Santos RHB, Silva Nunes JP, et al. Impairment of multiple mitochondrial energy metabolism pathways in the heart of Chagas disease cardiomyopathy patients. Front Immunol. 2021;12:755782. https:\/\/doi.org\/10.3389\/fimmu.2021.755782.","journal-title":"Front Immunol"},{"key":"718_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101490","volume":"31","author":"D Cruz-Topete","year":"2020","unstructured":"Cruz-Topete D, Dominic P, Stokes KY. Uncovering sex-specific mechanisms of action of testosterone and redox balance. Redox Biol. 2020;31:101490. https:\/\/doi.org\/10.1016\/j.redox.2020.101490.","journal-title":"Redox Biol"},{"key":"718_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.610516","volume":"8","author":"S Lynch","year":"2021","unstructured":"Lynch S, Boyett JE, Smith MR, Giordano-Mooga S. Sex hormone regulation of proteins modulating mitochondrial metabolism, dynamics and inter-organellar cross talk in cardiovascular disease. Front Cell Dev Biol. 2021;8:610516. https:\/\/doi.org\/10.3389\/fcell.2020.610516.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"718_CR52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.cjca.2016.03.017","volume":"32","author":"KM Keller","year":"2016","unstructured":"Keller KM, Howlett SE. Sex differences in the biology and pathology of the aging heart. Can J Cardiol. 2016;32(9):1065\u201373. https:\/\/doi.org\/10.1016\/j.cjca.2016.03.017.","journal-title":"Can J Cardiol"},{"issue":"9","key":"718_CR53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1042\/CS20160485","volume":"131","author":"R Ventura-Clapier","year":"2017","unstructured":"Ventura-Clapier R, Moulin M, Piquereau J, Lemaire C, Mericskay M, Veksler V, et al. Mitochondria: a central target for sex differences in pathologies. Clin Sci (Lond). 2017;131(9):803\u201322. https:\/\/doi.org\/10.1042\/CS20160485.","journal-title":"Clin Sci (Lond)"},{"key":"718_CR54","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fendo.2019.00557","volume":"10","author":"R Ventura-Clapier","year":"2019","unstructured":"Ventura-Clapier R, Piquereau J, Veksler V, Garnier A, Estrogens. Estrogen receptors effects on cardiac and skeletal muscle mitochondria. Front Endocrinol (Lausanne). 2019;10:557. https:\/\/doi.org\/10.3389\/fendo.2019.00557.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"718_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958200","volume":"13","author":"P Brochet","year":"2022","unstructured":"Brochet P, Ianni BM, Laugier L, Frade AF, Silva Nunes JP, Teixeira PC, et al. Epigenetic regulation of transcription factor binding motifs promotes Th1 response in Chagas disease cardiomyopathy. Front Immunol. 2022;13:958200. https:\/\/doi.org\/10.3389\/fimmu.2022.958200.","journal-title":"Front Immunol"},{"key":"718_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2025.103729","volume":"86","author":"D Talanaite","year":"2025","unstructured":"Talanaite D, Wang H, Qi M, Lan F. Generation of a human embryonic stem cell line (WAe009-A-3B) carrying homozygous TNNT2 gene knockout by CRISPR\/Cas9 editing. Stem Cell Res. 2025;86:103729. https:\/\/doi.org\/10.1016\/j.scr.2025.103729.","journal-title":"Stem Cell Res"},{"issue":"1","key":"718_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41431-022-01204-9","volume":"31","author":"TT Koopmann","year":"2023","unstructured":"Koopmann TT, Jamshidi Y, Naghibi-Sistani M, van der Klift HM, Birjandi H, Al-Hassnan Z, et al. Biallelic loss of LDB3 leads to a lethal pediatric dilated cardiomyopathy. Eur J Hum Genet. 2023;31(1):97\u2013104. https:\/\/doi.org\/10.1038\/s41431-022-01204-9.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"718_CR58","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.gendis.2021.04.007","volume":"9","author":"Q Lu","year":"2021","unstructured":"Lu Q, Pan B, Bai H, Zhao W, Liu L, Li G, et al. Intranuclear cardiac troponin I plays a functional role in regulating Atp2a2 expression in cardiomyocytes. Genes Dis. 2021;9(6):1689\u2013700. https:\/\/doi.org\/10.1016\/j.gendis.2021.04.007.","journal-title":"Genes Dis"},{"issue":"1","key":"718_CR59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cphy.c150016","volume":"6","author":"D Shao","year":"2015","unstructured":"Shao D, Tian R. Glucose transporters in cardiac metabolism and hypertrophy. Compr Physiol. 2015;6(1):331\u201351. https:\/\/doi.org\/10.1002\/cphy.c150016.","journal-title":"Compr Physiol"},{"issue":"6","key":"718_CR60","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201855RR","volume":"37","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wu L, Liu J, Ma L, Zhang W. Adenine nucleotide translocase: current knowledge in post-translational modifications, regulations and pathological implications for human diseases. FASEB J. 2023;37(6):e22953. https:\/\/doi.org\/10.1096\/fj.202201855RR.","journal-title":"FASEB J"},{"issue":"2","key":"718_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/cdd.2014.173","volume":"22","author":"DJ Roberts","year":"2015","unstructured":"Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ. 2015;22(2):248\u201357. https:\/\/doi.org\/10.1038\/cdd.2014.173.","journal-title":"Cell Death Differ"},{"issue":"22","key":"718_CR62","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1177\/15353702231220658","volume":"248","author":"JPS Nunes","year":"2023","unstructured":"Nunes JPS, Roda VMP, Andrieux P, Kalil J, Chevillard C, Cunha-Neto E. Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy. Exp Biol Med (Maywood). 2023;248(22):2062\u201371. https:\/\/doi.org\/10.1177\/15353702231220658.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"718_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00593-5","volume":"9","author":"H Li","year":"2023","unstructured":"Li H, Zhang M, Zhao Q, Zhao W, Zhuang Y, Wang J, et al. Self-recruited neutrophils trigger over-activated innate immune response and phenotypic change of cardiomyocytes in fulminant viral myocarditis. Cell Discov. 2023;9(1):103. https:\/\/doi.org\/10.1038\/s41421-023-00593-5.","journal-title":"Cell Discov"},{"issue":"12","key":"718_CR64","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.4049\/jimmunol.1602175","volume":"198","author":"MH Aziz","year":"2017","unstructured":"Aziz MH, Cui K, Das M, Brown KE, Ardell CL, Febbraio M, et al. The upregulation of integrin \u03b1D\u03b22 (CD11d\/CD18) on inflammatory macrophages promotes macrophage retention in vascular lesions and development of atherosclerosis. J Immunol. 2017;198(12):4855\u201367. https:\/\/doi.org\/10.4049\/jimmunol.1602175.","journal-title":"J Immunol"},{"issue":"4","key":"718_CR65","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10517-025-06355-5","volume":"178","author":"H Zhu","year":"2025","unstructured":"Zhu H, Liu L, Yang M, Zhu X, Cai J, Huang H. Nephroblastoma overexpressed protein (NOV\/CCN3) elevated expression of inflammation regulators in a model of sepsis-induced lung injury. Bull Exp Biol Med. 2025;178(4):453\u20139. https:\/\/doi.org\/10.1007\/s10517-025-06355-5.","journal-title":"Bull Exp Biol Med"},{"key":"718_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02791","volume":"9","author":"C Chevillard","year":"2018","unstructured":"Chevillard C, Nunes JPS, Frade AF, Almeida RR, Pandey RP, Nascimento MS, et al. Disease tolerance and pathogen resistance genes may underlie Trypanosoma cruzi persistence and differential progression to Chagas disease cardiomyopathy. Front Immunol. 2018;9:2791. https:\/\/doi.org\/10.3389\/fimmu.2018.02791.","journal-title":"Front Immunol"},{"key":"718_CR67","doi-asserted-by":"publisher","first-page":"8862004","DOI":"10.1155\/mi\/8862004","volume":"2025","author":"AF Frade","year":"2025","unstructured":"Frade AF, Gu\u00e9rin H, Nunes JPS, Silva LFSE, Roda VMP, Madeira RP, et al. Cardiac and digestive forms of Chagas disease: an update on Pathogenesis, Genetics, and therapeutic targets. Mediators Inflamm. 2025;2025:8862004. https:\/\/doi.org\/10.1155\/mi\/8862004.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"718_CR68","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s10875-021-01000-y","volume":"41","author":"M Ouarhache","year":"2021","unstructured":"Ouarhache M, Marquet S, Frade AF, Ferreira AM, Ianni B, Almeida RR, et al. Rare pathogenic variants in mitochondrial and inflammation-associated genes may lead to inflammatory cardiomyopathy in Chagas disease. J Clin Immunol. 2021;41(5):1048\u201363. https:\/\/doi.org\/10.1007\/s10875-021-01000-y.","journal-title":"J Clin Immunol"},{"issue":"4","key":"718_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/hearts4040013","volume":"4","author":"F Gallardo","year":"2023","unstructured":"Gallardo F, Brochet P, Gouden\u00e8ge D, Nunes JPS, Andrieux P, Ianni BM, et al. Mitochondrial DNA haplogroups and variants predispose to Chagas disease cardiomyopathy. Hearts. 2023;4(4):97\u2013117. https:\/\/doi.org\/10.3390\/hearts4040013.","journal-title":"Hearts"},{"issue":"4","key":"718_CR70","first-page":"225","volume":"60","author":"ACP Barretto","year":"1993","unstructured":"Barretto ACP, Arteaga E, Mady C, Ianni BM, Bellotti G, Pileggi F. Male sex. Prognostic factor in Chagas disease. Arq Bras Cardiol. 1993;60(4):225\u20137.","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"718_CR71","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.healun.2009.10.014","volume":"29","author":"ND Bertolino","year":"2010","unstructured":"Bertolino ND, Villafanha DF, Cardinalli-Neto A, Cordeiro J\u00c1, Arcanjo MJ, Theodoropoulos TAD, et al. Prognostic impact of Chagas disease in patients awaiting heart transplantation. J Heart Lung Transplant. 2010;29(4):449\u201353.","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"718_CR72","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ijcard.2012.01.033","volume":"167","author":"LG Villas Boas","year":"2013","unstructured":"Villas Boas LG, Bestetti RB, Otaviano AP, Cardinalli-Neto A, Nogueira PR. Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy. Int J Cardiol. 2013;167(2):486\u201390.","journal-title":"Int J Cardiol"},{"issue":"1","key":"718_CR73","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0002-9149(83)90085-1","volume":"52","author":"JSM Oliveira","year":"1983","unstructured":"Oliveira JSM, Araujo RLC, Navarro MA, Muccillo G. Cardiac thrombosis and thromboembolism in chronic Chagas heart disease. Am J Cardiol. 1983;52(1):147\u201351.","journal-title":"Am J Cardiol"},{"issue":"9","key":"718_CR74","first-page":"1284","volume":"11","author":"AP Mansur","year":"2023","unstructured":"Mansur AP, Pereira-Barretto AC, del Carlo CH, Ianni BM, Avakian SD, Gon\u00e7alinho GHF, et al. Sex differences in prognosis of heart failure due to chronic Chagas cardiomyopathy. JACC: Heart Failure. 2023;11(9):1284\u20136.","journal-title":"JACC: Heart Failure"},{"issue":"6","key":"718_CR75","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1590\/S0066-782X2011005000112","volume":"97","author":"AP Barbosa","year":"2011","unstructured":"Barbosa AP, Cardinalli-Neto A, Otaviano AP, Rocha BF, Bestetti RB. Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy. Arq Bras Cardiol. 2011;97(6):517\u201325.","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"718_CR76","doi-asserted-by":"publisher","first-page":"e004361","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","volume":"10","author":"L Shen","year":"2017","unstructured":"Shen L, Ramires F, Martinez F, Bodanese LC, Echeverria LC, Gomes EA, et al. Contemporary characteristics and outcomes in Chagasic heart failure compared with other non-ischemic and ischemic cardiomyopathy. Circ Heart Fail. 2017;10(11):e004361.","journal-title":"Circ Heart Fail"},{"key":"718_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2025.133088","volume":"426","author":"RB Bestetti","year":"2025","unstructured":"Bestetti RB, Otaviano AP, Cardinalli-Neto A, Machado MN, Nakazone MA. Clinical characteristics, predictors of mortality, and outcome in patients with heart failure with mildly reduced ejection fraction secondary to Chagas cardiomyopathy. Int J Cardiol. 2025;426:133088.","journal-title":"Int J Cardiol"},{"issue":"10422","key":"718_CR78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01787-7","volume":"403","author":"AS Souza","year":"2024","unstructured":"Souza AS, Vermeij D, Ramos-Jr NA, Luquetti AO. Chagas disease. Lancet. 2024;403(10422):203\u201318.","journal-title":"Lancet"},{"issue":"7","key":"718_CR79","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"SA Hunt","year":"2001","unstructured":"Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS. ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Am Coll Cardiol. 2001;38(7):2101\u201313.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"718_CR80","doi-asserted-by":"publisher","first-page":"e2015072","DOI":"10.1001\/jamanetworkopen.2020.15072","volume":"3","author":"S Chadalawada","year":"2020","unstructured":"Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao P, et al. Risk of chronic cardiomyopathy among patients with the acute phase or indeterminate form of Chagas disease: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(8):e2015072.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"718_CR81","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0167-5273(85)90262-1","volume":"8","author":"R Espinosa","year":"1985","unstructured":"Espinosa R, Carrasco HA, Belandria F, Fuenmayor AM, Molina C, Gonzales R, et al. Life expectancy analysis in patients with Chagas disease: prognostic after one decade (1973\u20131983). Int J Cardiol. 1985;8(1):45\u201356.","journal-title":"Int J Cardiol"},{"issue":"5","key":"718_CR82","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4269\/ajtmh.1990.43.498","volume":"43","author":"F Zicker","year":"1990","unstructured":"Zicker F, Smith PG, Netto JC, Oliveira RM, Zicker EM. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for chagas\u2019 cardiopathy. Am J Trop Med Hyg. 1990;43(5):498\u2013505. https:\/\/doi.org\/10.4269\/ajtmh.1990.43.498.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"718_CR83","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1365-3156.2001.00726.x","volume":"6","author":"RB Bestetti","year":"2001","unstructured":"Bestetti RB. Predictors of unfavourable prognosis in Chagas disease. Trop Med Int Health. 2001;6(6):476\u201383.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"718_CR84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000112403","volume":"110","author":"MCV Moreira","year":"2008","unstructured":"Moreira MCV, Heringer-Walther S, Vessel N, Ventura TM, Wang Y, Shulteiss HP, et al. Prognostic value of natriuretic peptides in Chagas disease: a 3-year follow-up investigation. Cardiology. 2008;110(4):217\u201325.","journal-title":"Cardiology"},{"issue":"9331","key":"718_CR85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(02)09638-1","volume":"360","author":"ALP Ribeiro","year":"2002","unstructured":"Ribeiro ALP, Reis AM, Barros MVL, Souza MR, Rocha ALL, Perez AA, et al. Brain natriuretic peptide and left ventricular systolic dysfunction in Chagas disease. Lancet. 2002;360(9331):461\u20132.","journal-title":"Lancet"},{"issue":"5","key":"718_CR86","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ejhf.1771","volume":"22","author":"N Suthahar","year":"2020","unstructured":"Suthahar N, Meems LMG, Ho JE, de Boer RA. Sex-related differences in contemporary biomarkers for heart failure: a review. Eur J Heart Fail. 2020;22(5):775\u201388. https:\/\/doi.org\/10.1002\/ejhf.1771.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"718_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5858\/135.2.243","volume":"135","author":"SGM Saravia","year":"2011","unstructured":"Saravia SGM, Haberland A, Bartel S, Araujo R, Valda G, Reynaga DD, et al. Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch Pathol Lab Med. 2011;135(2):243\u20138. https:\/\/doi.org\/10.5858\/135.2.243.","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"718_CR88","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.clinbiochem.2013.06.011","volume":"46","author":"SGM Saravia","year":"2013","unstructured":"Saravia SGM, Haberland A, Bartel S, Araujo R, Valda G, Reynaga DD, et al. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic chagas\u2019 disease. Clin Biochem. 2013;46(15):1615\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.06.011.","journal-title":"Clin Biochem"},{"issue":"6","key":"718_CR89","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jelectrocard.2018.08.031","volume":"51","author":"BOF Brito","year":"2018","unstructured":"Brito BOF, Pinto-Filho MM, Cardoso CS, Di Lorenzo Oliveira C, Ferreira AM, de Oliveira LC, et al. Association between typical electrocardiographic abnormalities and NT-proBNP elevation in a large cohort of patients with Chagas disease from endemic area. J Electrocardiol. 2018;51(6):1039\u201343. https:\/\/doi.org\/10.1016\/j.jelectrocard.2018.08.031.","journal-title":"J Electrocardiol"},{"issue":"8","key":"718_CR90","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2005.06.067","volume":"46","author":"CE Rochitte","year":"2005","unstructured":"Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, \u00c1vila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with chagas\u2019 disease: A marker of disease severity. J Am Coll Cardiol. 2005;46(8):1553\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.067.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"718_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008795","volume":"14","author":"MMD Romano","year":"2020","unstructured":"Romano MMD, Moreira HT, Marin-Neto JA, Baccelli PE, Alenezi F, Klem I, et al. Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance. PLoS Negl Trop Dis. 2020;14(11):e0008795. https:\/\/doi.org\/10.1371\/journal.pntd.0008795.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"718_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011847","volume":"17","author":"EA Bocchi","year":"2023","unstructured":"Bocchi EA, Veiga Guimar\u00e3es G, Espinoza Romero C, Sato PK, Freitas VLT, Yamashiro Kanashiro EH, et al. Assessment of biomarkers and clinical parameters as predictors of survival in patients with Chagasic heart failure. PLoS Negl Trop Dis. 2023;17(12):e0011847.","journal-title":"PLoS Negl Trop Dis"},{"key":"718_CR93","doi-asserted-by":"publisher","first-page":"100605","DOI":"10.1016\/j.lanwpc.2022.100605","volume":"31","author":"EA Bocchi","year":"2022","unstructured":"Bocchi EA. Chagas\u2019 disease: the hidden enemy around the world. Lancet Reg Health West Pac. 2022;31:100605. https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100605.","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"718_CR94","doi-asserted-by":"publisher","first-page":"e0013053","DOI":"10.1371\/journal.pntd.0013053","volume":"19","author":"MTSS Lira","year":"2025","unstructured":"Lira MTSS, Furquim SR, Marchi DC, Maciel PC, Dantas RCT, Biselli B, et al. Left ventricular reverse remodeling: A predictor of survival in Chagasic cardiomyopathy patients with a reduced ejection fraction. EA PLoS Negl Trop Dis. 2025;19(4):e0013053. https:\/\/doi.org\/10.1371\/journal.pntd.0013053.","journal-title":"EA PLoS Negl Trop Dis"},{"issue":"2","key":"718_CR95","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/ehf2.13232","volume":"8","author":"VS Issa","year":"2021","unstructured":"Issa VS, Ayub-Ferreira SM, Schroyens M, Chizzola PR, Soares PR, Lage SHG, et al. The course of patients with Chagas heart disease during episodes of decompensated heart failure. ESC Heart Fail. 2021;8(2):1460\u201371. https:\/\/doi.org\/10.1002\/ehf2.13232.","journal-title":"ESC Heart Fail"},{"issue":"6","key":"718_CR96","doi-asserted-by":"publisher","first-page":"e20230269","DOI":"10.36660\/abc.20230269","volume":"120","author":"JA Marin-Neto","year":"2023","unstructured":"Marin-Neto JA, Rassi A Jr, Oliveira GMM, Correia LCL, Ramos J\u00fanior AN, Luquetti AO, et al. SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of Chagas disease \u2013\u20092023. Arq Bras Cardiol. 2023;120(6):e20230269. https:\/\/doi.org\/10.36660\/abc.20230269.","journal-title":"Arq Bras Cardiol"},{"issue":"8","key":"718_CR97","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jchf.2024.05.021","volume":"12","author":"EA Bocchi","year":"2024","unstructured":"Bocchi EA, Echeverria LE, Demacq C, de Barros E, Silva PGM, Mazza Barbosa L, et al. PARACHUTE-HF Investigators. Sacubitril\/Valsartan versus Enalapril in chronic Chagas cardiomyopathy: rationale and design of the PARACHUTE-HF trial. JACC Heart Fail. 2024;12(8):1473\u201386. https:\/\/doi.org\/10.1016\/j.jchf.2024.05.021.","journal-title":"JACC Heart Fail"},{"issue":"12","key":"718_CR98","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jacc.2017.08.004","volume":"70","author":"EA Bocchi","year":"2017","unstructured":"Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70(12):1510\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.004.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"718_CR99","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1473-3099(23)00687-4","volume":"24","author":"RB Bestetti","year":"2024","unstructured":"Bestetti RB, Bocchi EA. Shorter treatment in chronic Chagas disease: a new promise? Lancet Infect Dis. 2024;24(4):333\u20134. https:\/\/doi.org\/10.1016\/S1473-3099(23)00687-4.","journal-title":"Lancet Infect Dis"},{"issue":"2 Suppl 3","key":"718_CR100","first-page":"1","volume":"97","author":"JP Andrade","year":"2011","unstructured":"Andrade JP, Marin-Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. Sociedade Brasileira de Cardiologia. I diretriz Latino Americana Para o Diagn\u00f3stico e Tratamento Da cardiopatia Chag\u00e1sica [I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy]. Arq Bras Cardiol. 2011;97(2 Suppl 3):1\u201348.","journal-title":"Arq Bras Cardiol"},{"issue":"10136","key":"718_CR101","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/S0140-6736(18)30751-7","volume":"391","author":"E Bocchi","year":"2018","unstructured":"Bocchi E. Chagas disease cardiomyopathy treatment remains a challenge. Lancet. 2018;391(10136):2209. https:\/\/doi.org\/10.1016\/S0140-6736(18)30751-7.","journal-title":"Lancet"},{"issue":"11","key":"718_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003312","volume":"8","author":"DL Fabbro","year":"2014","unstructured":"Fabbro DL, Danesi E, Olivera V, et al. Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014;8(11):e3312. https:\/\/doi.org\/10.1371\/journal.pntd.0003312.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"718_CR103","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1590\/0074-02760140347","volume":"110","author":"G Moscatelli","year":"2015","unstructured":"Moscatelli G, Moroni S, Garc\u00eda-Bournissen F, et al. Prevention of congenital Chagas through treatment of girls and women of childbearing age. Mem Inst Oswaldo Cruz. 2015;110(4):507\u20139. https:\/\/doi.org\/10.1590\/0074-02760140347.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"718_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012407","volume":"18","author":"FCA Moraes","year":"2024","unstructured":"Moraes FCA, Souza MEC, Dal Moro L, et al. Prevention of congenital Chagas disease by trypanocide treatment in women of reproductive age: a meta-analysis of observational studies. PLoS Negl Trop Dis. 2024;18(9):e0012407. https:\/\/doi.org\/10.1371\/journal.pntd.0012407.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"718_CR105","doi-asserted-by":"publisher","first-page":"135","DOI":"10.31053\/1853.0605.v59.n2.38486","volume":"57","author":"RR Gallerano","year":"2000","unstructured":"Gallerano RR, Sosa RR. Estudio de intervenci\u00f3n En La evoluci\u00f3n natural de La Enfermedad de Chagas. Evaluaci\u00f3n Del Tratamiento antiparasitario espec\u00edfico. Estudio retrospectivo-prospectivo de terap\u00e9utica antiparasitaria. Rev Fac Cien Med Univ Nac Cordoba. 2000;57(2):135\u201362.","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"issue":"10","key":"718_CR106","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","volume":"144","author":"R Viotti","year":"2006","unstructured":"Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med. 2006;144(10):724\u201334. https:\/\/doi.org\/10.7326\/0003-4819-144-10-200605160-00006.","journal-title":"Ann Intern Med"},{"key":"718_CR107","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.eclinm.2024.102972","volume":"79","author":"A Rassi Jr","year":"2024","unstructured":"Rassi A Jr, Grimshaw A, Sarwal A, Sah R, Shah S, Agudelo Higuita NI, et al. Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis. EClinicalMedicine. 2024;79:102972. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102972.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"718_CR108","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/01.cir.75.6.1140","volume":"75","author":"JH Maguire","year":"1987","unstructured":"Maguire JH, Hoff R, Sherlock I, Guimar\u00e3es AC, Sleigh AC, Ramos NB, et al. Cardiac morbidity and mortality due to chagas\u2019 disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75(6):1140\u20135. https:\/\/doi.org\/10.1161\/01.cir.75.6.1140.","journal-title":"Circulation"},{"issue":"11","key":"718_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006814","volume":"12","author":"CS Cardoso","year":"2018","unstructured":"Cardoso CS, Ribeiro ALP, Oliveira CDL, Oliveira LC, Ferreira AM, Bierrenbach AL, et al. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study. PLoS Negl Trop Dis. 2018;12(11):e0006814. https:\/\/doi.org\/10.1371\/journal.pntd.0006814.","journal-title":"PLoS Negl Trop Dis"},{"issue":"14","key":"718_CR110","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"CA Morillo","year":"2015","unstructured":"Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A Jr, Rosas F, et al. Randomized trial of benznidazole for chronic chagas\u2019 cardiomyopathy. N Engl J Med. 2015;373(14):1295\u2013306. https:\/\/doi.org\/10.1056\/NEJMoa1507574.","journal-title":"N Engl J Med"},{"issue":"1","key":"718_CR111","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCHEARTFAILURE.109.882035","volume":"3","author":"VS Issa","year":"2010","unstructured":"Issa VS, Amaral AF, Cruz FD, Ferreira SM, Guimar\u00e3es GV, Chizzola PR, Souza GE, et al. Beta-blocker therapy and mortality of patients with Chagas cardiomyopathy: a subanalysis of the REMADHE prospective trial. Circ Heart Fail. 2010;3(1):82\u20138. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.882035.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"718_CR112","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jamacardio.2024.3169","volume":"9","author":"M Martinelli-Filho","year":"2024","unstructured":"Martinelli-Filho M, Marin-Neto JA, Scanavacca MI, Paola AAV, Medeiros PTJ, Owen R, et al. CHAGASICS investigators. Amiodarone or implantable Cardioverter-defibrillator in Chagas cardiomyopathy: the CHAGASICS randomized clinical trial. JAMA Cardiol. 2024;9(12):1073\u201381. https:\/\/doi.org\/10.1001\/jamacardio.2024.3169.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"718_CR113","first-page":"23","volume":"62","author":"EA Bocchi","year":"1994","unstructured":"Bocchi EA, Vieira ML, Fiorelli A, Hayashida S, Mayzato M, Leirner A, Stolf N, et al. Hemodynamic and neurohormonal profile during assisted circulation with heterotopic artificial ventricle followed by heart transplantation. Arq Bras Cardiol. 1994;62(1):23\u20137.","journal-title":"Arq Bras Cardiol"},{"issue":"6","key":"718_CR114","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/0003-4975(96)00141-5","volume":"61","author":"EA Bocchi","year":"1996","unstructured":"Bocchi EA, Bellotti G, Mocelin AO, Uip D, Bacal F, Higuchi ML, et al. Heart transplantation for chronic chagas\u2019 heart disease. Ann Thorac Surg. 1996;61(6):1727\u201333. https:\/\/doi.org\/10.1016\/0003-4975(96)00141-5.","journal-title":"Ann Thorac Surg"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-025-00718-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-025-00718-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:25:28Z","timestamp":1768544728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11897-025-00718-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s11897-025-00718-9","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}